Description: Sharon Chan, vice-president, Johnson & Johnson Innovation – JLABS Asia Pacific, talks to Scrip's Seoul-based senior editor Jung-Won Shin about a new project in South Korea for Johnson & Johnson's JLABS program, and on the attractions and potential of South Korea in the biopharma sector.
Time Stamps
00:20 South Korea’s strength as an emerging hub for biotech/medtech R&D
03:42 How JLABS Korea is different to those in Shanghai and Singapore
06:15 Innovative technologies J&J is looking for in Korea
07:52 Initial collaboration and other plans for JLABS Korea
10:02 Impact JLABS Korea may have on Korea’s biotech ecosystem
12:00 Steps Korea needs to make attract global biopharma firms